Effects of daily oral m-Chlorophenylpiperazine in elderly depressed patients initial experience with a serotonin agonist

Biological Psychiatry

Volumn 28, Issue 7, 1990, Pages 588-594

  Mellow, Alan M ^a   Lawlor, Brian A ^b   Sunderland, Trey ^c   Mueller, Edward A ^d   Molchan, Susan E ^c   Murphy, Dennis L ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d Rutland Mental Health Services Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE;

AGED; ARTICLE; CLINICAL ARTICLE; DEPRESSION; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

AGED; ANTIDEPRESSIVE AGENTS; BRAIN; CASE REPORT; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MIDDLE AGE; PILOT PROJECTS; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, SEROTONIN; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025184484     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(90)90396-J     Document Type: Article

References (32)

1. Psychobiology of suicide, impulsivity, and related phenomena
2. Serotonin and its place in the pathogenesis of depression
3. Abnormalities of indoleamines in affective disorders
4. Disposition and pharmacological effects of m-chlorophenylpiperazine in rats
5. 1-(m-chlorophenyl)piperazine (m-CPP) interactions with neurotransmitter receptors in the human brain
6. A rating scale for depression
7. 1C receptors
8. 1C receptor antagonists
9. Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects
10. Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease: A controlled study
11. Neuroendocrine effects of serotonergic agents: Applications to the study of central serotonin function in humans
12. A pilot clinical trial of m-chlorophenylpiperazine in depression
13. The serotonin hypothesis of depression
14. The dopamine and serotonin systems during aging in human and rodent brain: A brief review
15. A new postsynaptic serotonin agonist for studies in humans
16. Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist in humans
17. Further studies of the putative serotonin agonist m-chlorophenylpiperazine Evidence for a serotonin receptor mediated mechanism of action in humans
18. The brain serotonergic system in the affective disorders
19. Use of serotonergic agents in the clinical assessment of central serotonin function
20. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers
21. Obsessive compulsive disorder as a 5-HT subsystem-related behavioural disorder
22. Identification of 5-hydroxytryptamine-1D binding sites in human brain membranes
23. Serotonergic anxiolytics and treatment of depression
24. Suicidal behavior impulsiveness and serotonin
25. Open trial of buspirone in the treatment of major depressive disorder
26. Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated injection of either 5-MeODMT or m-CPP
27. 1A receptor-related anxiolytics
28. New evidence of serotonin-deficient depressions
29. Therapeutic indications for serotonin-potentiating compounds: A hypothesis
30. Antidepressants and serotonergic neurotransmission: An integrative review
31. Second generation anxiolytics and serotonin